Rep. Jennifer Wexton, D-Va., announced she would not be running for reelection and planned to retire following a diagnosis of progressive supranuclear palsy.
Speed is of the essence in NYU Langone neurology ads
FDA is slated to decide on several new anti-amyloid antibodies in Q1. The potential Alzheimer’s progress is just one reason this could be a transformative year in CNS.
The MM+M Podcast 2.5.21: inThought Research’s Dr. Leon Henderson-MacLennan
Leon Henderson-MacLennan, M.D., of inThought Research, joins Marc Iskowitz, editor-at-large for MM+M, to explain why January was a pivotal month in neuroscience and why marketers should watch this space.
Five things for pharma marketers to know: Monday, January 8, 2018